PT-141

PT-141, also known as Bremelanotide, is a synthetic peptide derived from α-melanocyte-stimulating hormone (α-MSH). Extensively studied for its high affinity toward melanocortin receptors, particularly MC-4R and MC-1R, PT-141 has gained interest in preclinical research focused on neuroendocrine signaling, immune modulation, and sexual function pathways.
This peptide plays a key role in the study of hypothalamic-pituitary interactions, making it valuable for ongoing in vitro investigations into neuropeptide-related responses and receptor dynamics.